FI20021617A7 - Diagnostisia ja terapeuttisia menetelmiä - Google Patents

Diagnostisia ja terapeuttisia menetelmiä

Info

Publication number: FI20021617A7
Authority: FI; Finland
Prior art keywords: diagnostic; therapeutic methods; therapeutic; methods
Prior art date: 2002-01-24

Application number

FI20021617A

Other languages

English (en)

Swedish (sv)

Other versions

FI20021617A0 (fi

FI113666B (fi

Inventor

Annamari Ranki

Boguslaw Nedoszytko

Leena Karenko

Tapio Visakorpi

Ritva Karhu

Marketta Kaehkoenen

Original Assignee

Annamari Ranki

Leena Karenko

Marketta Kaehkoenen

Ritva Karhu

Tapio Visakorpi

Boguslaw Nedoszytko

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-24

Filing date

2002-09-10

Publication date

2003-07-25

2002-01-24 Priority claimed from FI20020132A external-priority patent/FI20020132A7/fi

2002-09-10 Publication of FI20021617A0 publication Critical patent/FI20021617A0/fi

2002-09-10 Priority to FI20021617A priority Critical patent/FI113666B/fi

2002-09-10 Application filed by Annamari Ranki, Leena Karenko, Marketta Kaehkoenen, Ritva Karhu, Tapio Visakorpi, Boguslaw Nedoszytko filed Critical Annamari Ranki

2003-01-24 Priority to PCT/FI2003/000061 priority patent/WO2003066898A1/en

2003-01-24 Priority to AU2003201630A priority patent/AU2003201630A1/en

2003-01-24 Priority to EP03700329A priority patent/EP1476567A1/en

2003-01-24 Priority to US10/502,638 priority patent/US7803532B2/en

2003-01-24 Priority to CA 2474446 priority patent/CA2474446A1/en

2003-01-24 Priority to JP2003566246A priority patent/JP4782378B2/ja

2003-07-25 Publication of FI20021617A7 publication Critical patent/FI20021617A7/fi

2004-05-31 Publication of FI113666B publication Critical patent/FI113666B/fi

2004-05-31 Application granted granted Critical

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Hospice & Palliative Care (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Oncology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

FI20021617A 2002-01-24 2002-09-10 Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö FI113666B (fi)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
FI20021617A FI113666B (fi)	2002-01-24	2002-09-10	Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö
PCT/FI2003/000061 WO2003066898A1 (en)	2002-01-24	2003-01-24	A method for the diagnosis of lymphoproliferative diseases
JP2003566246A JP4782378B2 (ja)	2002-01-24	2003-01-24	リンパ球異常増殖疾患の診断方法
AU2003201630A AU2003201630A1 (en)	2002-01-24	2003-01-24	A method for the diagnosis of lymphoproliferative diseases
EP03700329A EP1476567A1 (en)	2002-01-24	2003-01-24	A method for the diagnosis of lymphoproliferative diseases
US10/502,638 US7803532B2 (en)	2002-01-24	2003-01-24	Method for the diagnosis of lymphoproliferative diseases
CA 2474446 CA2474446A1 (en)	2002-01-24	2003-01-24	A method for the diagnosis of lymphoproliferative diseases

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FI20020132		2002-01-24
FI20020132A FI20020132A7 (fi)	2002-01-24	2002-01-24	Diagnostisia ja terapeuttisia menetelmiä
FI20021617A FI113666B (fi)	2002-01-24	2002-09-10	Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö
FI20021617		2002-09-10

Publications (3)

Publication Number	Publication Date
FI20021617A0 FI20021617A0 (fi)	2002-09-10
FI20021617A7 true FI20021617A7 (fi)	2003-07-25
FI113666B FI113666B (fi)	2004-05-31

Family

ID=26161265

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI20021617A FI113666B (fi)	2002-01-24	2002-09-10	Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö

Country Status (7)

Country	Link
US (1)	US7803532B2 (fi)
EP (1)	EP1476567A1 (fi)
JP (1)	JP4782378B2 (fi)
AU (1)	AU2003201630A1 (fi)
CA (1)	CA2474446A1 (fi)
FI (1)	FI113666B (fi)
WO (1)	WO2003066898A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0878552A1 (en)	1997-05-13	1998-11-18	Erasmus Universiteit Rotterdam	Molecular detection of chromosome aberrations
WO1999057309A1 (en)	1998-05-04	1999-11-11	Dako A/S	Method and probes for the detection of chromosome aberrations
US8143029B2 (en)	2005-12-22	2012-03-27	Valipharma	Methods and means related to diseases
PL2092081T3 (pl) *	2006-11-13	2013-07-31	Valipharma	Sposoby i zastosowania obejmujące genetyczne nieprawidłowości w chromosomie 12
ES2534769T3 (es)	2007-09-20	2015-04-28	Valipharma	Diagnóstico de linfoma de linfocitos B
WO2009126804A2 (en) *	2008-04-11	2009-10-15	The Regents Of The University Of Colorado, A Body Corporate	Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis
ES2469802T3 (es) *	2008-10-20	2014-06-20	Valipharma	Métodos y usos que implican aberraciones genéticas de NAV 3 y expresión aberrante de múltiples genes
WO2021061752A1 (en) *	2019-09-23	2021-04-01	Neonc Technologies, Inc.	Pharmaceutical compositions comprising poh derivatives
US20230057230A1 (en)	2020-03-16	2023-02-23	Mandom Corporation	Method for detecting indicator of t-cell lymphoma and utilization thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6007994A (en) *	1995-12-22	1999-12-28	Yale University	Multiparametric fluorescence in situ hybridization
ES2534769T3 (es) *	2007-09-20	2015-04-28	Valipharma	Diagnóstico de linfoma de linfocitos B

2002
- 2002-09-10 FI FI20021617A patent/FI113666B/fi not_active IP Right Cessation
2003
- 2003-01-24 JP JP2003566246A patent/JP4782378B2/ja not_active Expired - Fee Related
- 2003-01-24 AU AU2003201630A patent/AU2003201630A1/en not_active Abandoned
- 2003-01-24 CA CA 2474446 patent/CA2474446A1/en not_active Abandoned
- 2003-01-24 WO PCT/FI2003/000061 patent/WO2003066898A1/en not_active Ceased
- 2003-01-24 EP EP03700329A patent/EP1476567A1/en not_active Withdrawn
- 2003-01-24 US US10/502,638 patent/US7803532B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2003066898A1 (en)	2003-08-14
AU2003201630A1 (en)	2003-09-02
US7803532B2 (en)	2010-09-28
FI20021617A0 (fi)	2002-09-10
EP1476567A1 (en)	2004-11-17
JP4782378B2 (ja)	2011-09-28
US20050221309A1 (en)	2005-10-06
CA2474446A1 (en)	2003-08-14
FI113666B (fi)	2004-05-31
JP2005518790A (ja)	2005-06-30

Publication	Publication Date	Title
NO20041872L (no)	2004-05-06	Esterforbindelser og medisinsk anvendelse derav
DE60331861D1 (de)	2010-05-06	Ultraschallverfahren und ultraschallgerät
NO20034465D0 (no)	2003-10-06	Medisinsk pasientsimulator
DE60336485D1 (de)	2011-05-05	Kombinationstherapie gegen hyperproliferative erkrankungen
DE60301989D1 (de)	2005-12-01	Medizinisches Ultraschallsystem
DE60328797D1 (de)	2009-09-24	Blutbehandlungsgerät
DE60315135D1 (de)	2007-09-06	Therapiesonde
DE60235204D1 (de)	2010-03-11	Medizinische leitung und leitungsverbindungssystem
DE50311558D1 (de)	2009-07-09	Inhalationstherapievorrichtung
DE60327090D1 (de)	2009-05-20	Implantierbare medizinische vorrichtung
EP1572741A4 (en)	2006-09-27	DIAGNOSTIC AND THERAPEUTIC AGENTS
EP1494530A4 (en)	2009-06-24	COMBINATION THERAPY USING TREFLE LEAF PEPTIDES
DK1513836T3 (da)	2006-09-11	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
EP1570270A4 (en)	2010-09-22	THERAPEUTIC BIOKON JUGATE
DK1597171T3 (da)	2013-02-11	Terapeutisk mikroskum
DE50300206D1 (de)	2005-01-20	Medizinisches instrument
EP1781685A4 (en)	2008-06-25	THERAPEUTIC AND DIAGNOSTIC AGENTS
GB0303663D0 (en)	2003-03-19	Assays and medical treatments
NO20050689L (no)	2005-03-21	Terapeutisk anvendelse
DK1553950T3 (da)	2007-10-15	Terapeutisk behandling
FI20021617A0 (fi)	2002-09-10	Diagnostisia ja terapeuttisia menetelmiä
EP1483407A4 (en)	2006-11-15	THERAPEUTIC AND DIAGNOSTIC METHODS
DE50300117D1 (de)	2004-11-25	Medizinisches instrument
FI20020132A7 (fi)	2003-07-25	Diagnostisia ja terapeuttisia menetelmiä
NO20022747L (no)	2003-12-08	Behandlingsstol

Legal Events

Date	Code	Title	Description
2006-01-13	PC	Transfer of assignment of patent	Owner name: HELSINGIN YLIOPISTO Free format text: HELSINGIN YLIOPISTO
2006-10-18	PC	Transfer of assignment of patent	Owner name: DERMAGENE OY Free format text: DERMAGENE OY
2010-04-12	PC	Transfer of assignment of patent	Owner name: HELSINGIN YLIOPISTON RAHASTOT Free format text: HELSINGIN YLIOPISTON RAHASTOT
2016-02-05	PC	Transfer of assignment of patent	Owner name: VALIPHARMA
2018-04-25	MM	Patent lapsed